Free Trial

Shield Therapeutics (STX) Competitors

Shield Therapeutics logo
GBX 2.35 -0.30 (-11.32%)
As of 04/17/2025 11:50 AM Eastern

STX vs. ELX, APC, DGI, STK, IDEA, VLG, DNL, EAH, PXS, and CHLL

Should you be buying Shield Therapeutics stock or one of its competitors? The main competitors of Shield Therapeutics include El Oro (ELX), Apc Technology Group (APC), DG Innovate (DGI), StreaksAI (STK), Ideagen (IDEA), Venture Life Group (VLG), Diurnal Group (DNL), ECO Animal Health Group (EAH), Provexis (PXS), and Chill Brands Group (CHLL).

Shield Therapeutics vs.

El Oro (LON:ELX) and Shield Therapeutics (LON:STX) are both small-cap manufacturing companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, community ranking and risk.

In the previous week, El Oro's average media sentiment score of 0.00 equaled Shield Therapeutics'average media sentiment score.

Company Overall Sentiment
El Oro Neutral
Shield Therapeutics Neutral

Shield Therapeutics received 162 more outperform votes than El Oro when rated by MarketBeat users. Likewise, 75.17% of users gave Shield Therapeutics an outperform vote while only 59.55% of users gave El Oro an outperform vote.

CompanyUnderperformOutperform
El OroOutperform Votes
53
59.55%
Underperform Votes
36
40.45%
Shield TherapeuticsOutperform Votes
215
75.17%
Underperform Votes
71
24.83%

11.9% of Shield Therapeutics shares are owned by institutional investors. 62.2% of Shield Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

El Oro has higher earnings, but lower revenue than Shield Therapeutics. Shield Therapeutics is trading at a lower price-to-earnings ratio than El Oro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
El Oro-£7.25M0.00N/A-£2.50N/A
Shield Therapeutics£20.92M1.11-£36.28M-£3.88-0.61

El Oro has a net margin of 0.00% compared to Shield Therapeutics' net margin of -173.43%. El Oro's return on equity of 0.00% beat Shield Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
El OroN/A N/A N/A
Shield Therapeutics -173.43%-470.50%-47.85%

Summary

Shield Therapeutics beats El Oro on 6 of the 10 factors compared between the two stocks.

Get Shield Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STX and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STX vs. The Competition

MetricShield TherapeuticsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£23.19M£2.13B£5.30B£2.50B
Dividend YieldN/A2.92%5.45%4.79%
P/E Ratio-0.614.3321.86130.25
Price / Sales1.11478.32380.66234,001.07
Price / Cash6.3610.2538.2628.23
Price / Book42.946.146.454.41
Net Income-£36.28M£20.70B£3.22B£5.87B
1 Month Performance-21.93%-3.01%-9.76%-1.38%
1 Year Performance62.07%93.89%11.49%41.26%

Shield Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STX
Shield Therapeutics
N/AGBX 2.35
-11.3%
N/A+62.1%£23.19M£20.92M-0.6140,000Gap Down
High Trading Volume
ELX
El Oro
N/AN/AN/AN/A£41.06M£-7,248,605.00-26.001,122
APC
Apc Technology Group
N/AN/AN/AN/A£18.03M£19.20M19.75164,000
DGI
DG Innovate
N/AN/AN/AN/A£1.90M£24,500.00-1.25790Gap Down
STK
StreaksAI
N/AGBX 0.47
+4.4%
N/A-14.5%£1.78MN/A-32.503Gap Up
IDEA
Ideagen
N/AN/AN/AN/A£1.03B£75.28M17,450.009Positive News
VLG
Venture Life Group
N/AGBX 40.42
-0.2%
N/A+5.3%£51.51M£51.77M68.60165News Coverage
DNL
Diurnal Group
N/AN/AN/AN/A£46.33M£4.68M-3.2133
EAH
ECO Animal Health Group
N/AGBX 53
-0.9%
N/A-43.2%£35.91M£89.44M34.26234
PXS
Provexis
N/AGBX 0.52
-6.4%
N/A-17.6%£12.09M£846,984.38-19.524Gap Down
CHLL
Chill Brands Group
N/AN/AN/AN/A£10.89M£624,187.00-215.007

Related Companies and Tools


This page (LON:STX) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners